103 - Mano-a-Mano

Friday, October 1, 2021

4:15 PM - 5:30 PM EDT

Moderator(s)

Hayley Gans, MD

Professor
Stanford Univ Med Ctr
Palo Alto, CA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Gabriella Lamb, MD, MPH

Assistant in Pediatrics, Director of Quality Improvement, Division of Infectious Diseases
Pediatrics
Boston Children's Hospital
Boston, Massachusetts, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

WM

William Muller, MD, PhD

Associate Professor
Pediatrics
Northwestern University
Chicago, IL, United States

Ansun (Individual(s) Involved: Self): Grant/Research Support; Astellas (Individual(s) Involved: Self): Research Grant or Support; AstraZeneca (Individual(s) Involved: Self): Grant/Research Support; BD (Individual(s) Involved: Self): Research Grant or Support; Eli Lilly (Individual(s) Involved: Self): Grant/Research Support; Gilead (Individual(s) Involved: Self): Grant/Research Support; Karius, Inc. (Individual(s) Involved: Self): Grant/Research Support, Scientific Research Study Investigator; Melinta (Individual(s) Involved: Self): Grant/Research Support; Merck (Individual(s) Involved: Self): Grant/Research Support; Moderna (Individual(s) Involved: Self): Grant/Research Support; Nabriva (Individual(s) Involved: Self): Grant/Research Support; Seqirus (Individual(s) Involved: Self): Consultant; Tetraphase (Individual(s) Involved: Self): Grant/Research Support
Nanda Ramchandar, MD,MPH

Pediatric Infectious Disease
Naval Medical Center San Diego
Carlsbad, CA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Surabhi (Sara) Vora, MD, MPH

Associate Professor
Seattle Children's Hospital
Seattle, Washington, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rebecca Same, MD

Assistant Professor
Washington University School of Medicine in St. Louis

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Isaac Thomsen, MD, MSCI

Associate Professor, Pediatric Infectious Diseases
Vanderbilt University Medical Center
Nashville, TN, United States

Horizon Therapeutics (Individual(s) Involved: Self): Consultant
James Wood, MD, MSCI

Assistant Professor of Pediatrics
Indiana University School of Medicine
Indianapolis, IN, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Hayley Gans, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Gabriella S. Lamb, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

William J. Muller, MD, PhD: Ansun (Individual(s) Involved: Self): Grant/Research Support; Astellas (Individual(s) Involved: Self): Research Grant or Support; AstraZeneca (Individual(s) Involved: Self): Grant/Research Support; BD (Individual(s) Involved: Self): Research Grant or Support; Eli Lilly (Individual(s) Involved: Self): Grant/Research Support; Gilead (Individual(s) Involved: Self): Grant/Research Support; Karius, Inc. (Individual(s) Involved: Self): Grant/Research Support, Scientific Research Study Investigator; Melinta (Individual(s) Involved: Self): Grant/Research Support; Merck (Individual(s) Involved: Self): Grant/Research Support; Moderna (Individual(s) Involved: Self): Grant/Research Support; Nabriva (Individual(s) Involved: Self): Grant/Research Support; Seqirus (Individual(s) Involved: Self): Consultant; Tetraphase (Individual(s) Involved: Self): Grant/Research Support

Nanda Ramchandar, MD,MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Surabhi (Sara) Vora, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rebecca Same, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Isaac Thomsen, MD, MSCI: Horizon Therapeutics (Individual(s) Involved: Self): Consultant

James Wood, MD, MSCI: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE credits

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss the pros and cons of clinical Utilization of next-generation sequencing
explain the value regarding line removal or retention in Staphylococcus aureus line infection

Presentations:

Clinical Utilization of Next-generation Sequencing (con)
Debate Style Speaker: William J. Muller, MD, PhD – Northwestern University
Clinical Utilization of Next-generation Sequencing (pro)
Debate Style Speaker: Nanda Ramchandar, MD,MPH – Naval Medical Center San Diego
Fixed Duration of Antibiotics for Bacteremia in the neutropenic patient - Con side-duration dependent on count recovery
Debate Style Speaker: Surabhi (Sara) Vora, MD, MPH – Seattle Children's Hospital
Fixed Duration of Antibiotics for Bacteremia in the neutropenic patient - Pro side-fixed duration
Debate Style Speaker: Rebecca Same, MD – Washington University School of Medicine in St. Louis
Staphylococcus aureus Line Infections: To Remove or Retain (remove)
Debate Style Speaker: Isaac Thomsen, MD, MSCI – Vanderbilt University Medical Center
Staphylococcus aureus Line Infections: To Remove or Retain (retain)
Debate Style Speaker: James Wood, MD, MSCI – Indiana University School of Medicine